硬脂酰辅酶A去饱和酶通过稳定低密度脂蛋白受体相关蛋白5和6形成Wnt正反馈信号环促进小鼠肝纤维化与肿瘤发生
研究探讨硬脂酰辅酶A去饱和酶(SCD)促进小鼠肝纤维化与肿瘤发展的机制。SCD在活化肝星状细胞和肝癌细胞中过表达,其mRNA水平与肝癌分期及患者生存时间相关;SCD产生的单不饱和脂肪酸通过稳定LRP5和LRP6 mRNA放大Wnt信号,形成正反馈环。遗传或药物抑制SCD可减轻小鼠肝纤维化与肿瘤发生。
要点
- SCD在活化肝星状细胞和肝癌细胞中过表达,其mRNA水平与肝癌分期及患者生存时间相关。
- SCD产生的单不饱和脂肪酸通过稳定LRP5和LRP6 mRNA放大Wnt信号,形成正反馈环。
- 遗传或药物抑制SCD可减轻小鼠肝纤维化与肿瘤发生。
核心结论
- 在啮齿类肝星状细胞和肿瘤起始细胞中,SCD表达受Wnt-β-catenin信号调控,SCD产生的单不饱和脂肪酸通过稳定Lrp5和Lrp6 mRNA形成正反馈环放大Wnt信号,促进肝纤维化与肿瘤生长。
- 肝星状细胞表达的SCD促进小鼠肝脏肿瘤发展,该信号环组分可能成为肝纤维化与肿瘤的治疗靶点。
研究设计与样本
- 研究使用啮齿类原代肝星状细胞、小鼠肝脏肿瘤起始干细胞样细胞及人肝癌细胞系,并采用药理学和条件性遗传操作在肝毒性或胆汁淤积诱导肝纤维化、原位移植肿瘤起始细胞或二乙基亚硝胺诱导肝肿瘤的小鼠中评估SCD功能。
- 对患者肝癌与非肿瘤肝组织的SCD表达进行生物信息学分析,并与肝癌分期和患者死亡率进行关联。
- 采用纳米珠下拉实验、液相色谱-质谱联用、计算建模和核糖核蛋白免疫沉淀分析鉴定单不饱和脂肪酸相互作用蛋白,并通过免疫印迹和定量聚合酶链反应分析SCD抑制对Wnt信号及LRP5和LRP6表达与稳定性的影响。
主要发现
- SCD在患者活化肝星状细胞和肝癌细胞中过表达,SCD信使RNA水平与肝癌分期及患者生存时间相关。
- 在啮齿类肝星状细胞和肿瘤起始细胞中,Wnt效应因子β-catenin增加甾醇调节元件结合蛋白1依赖的Scd转录,而SCD产生的单不饱和脂肪酸反过来稳定β-catenin。
- 该环路需要单不饱和脂肪酸抑制Ras相关核蛋白1与转运蛋白1结合并减少elav样蛋白1的核输入,增加胞质HuR水平及HuR介导的LRP5和LRP6 mRNA稳定性。
- 遗传破坏Scd及药理学SCD抑制剂减少肝星状细胞活化和肿瘤起始细胞自我更新,并减轻小鼠肝纤维化和肿瘤发生。
- 在活化肝星状细胞中条件性破坏Scd2可阻止肿瘤起始细胞来源肿瘤生长,并减少二乙基亚硝胺诱导的小鼠肝肿瘤形成。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Stearoyl-CoA desaturase (SCD) synthesizes monounsaturated fatty acids (MUFAs) and has been associated with the development of metabolic syndrome, tumorigenesis, and stem cell characteristics. We investigated whether and how SCD promotes liver fibrosis and tumor development in mice. METHODS: Rodent primary hepatic stellate cells (HSCs), mouse liver tumor-initiating stem cell-like cells (TICs), and human hepatocellular carcinoma (HCC) cell lines were exposed to Wnt signaling inhibitors and changes in gene expression patterns were analyzed. We assessed the functions of SCD by pharmacologic and conditional genetic manipulation in mice with hepatotoxic or cholestatic induction of liver fibrosis, orthotopic transplants of TICs, or liver tumors induced by administration of diethyl nitrosamine. We performed bioinformatic analyses of SCD expression in HCC vs nontumor liver samples collected from patients, and correlated levels with HCC stage and patient mortality. We performed nano-bead pull-down assays, liquid chromatography-mass spectrometry, computational modeling, and ribonucleoprotein immunoprecipitation analyses to identify MUFA-interacting proteins. We examined the effects of SCD inhibition on Wnt signaling, including the expression and stability of low-density lipoprotein-receptor-related proteins 5 and 6 (LRP5 and LRP6), by immunoblot and quantitative polymerase chain reaction analyses. RESULTS: SCD was overexpressed in activated HSC and HCC cells from patients; levels of SCD messenger RNA (mRNA) correlated with HCC stage and patient survival time. In rodent HSCs and TICs, the Wnt effector β-catenin increased sterol regulatory element binding protein 1-dependent transcription of Scd, and β-catenin in return was stabilized by MUFAs generated by SCD. This loop required MUFA inhibition of binding of Ras-related nuclear protein 1 (Ran1) to transportin 1 and reduced nuclear import of elav-like protein 1 (HuR), increasing cytosolic levels of HuR and HuR-mediated stabilization of mRNAs encoding LRP5 and LRP6. Genetic disruption of Scd and pharmacologic inhibitors of SCD reduced HSC activation and TIC self-renewal and attenuated liver fibrosis and tumorigenesis in mice. Conditional disruption of Scd2 in activated HSCs prevented growth of tumors from TICs and reduced the formation of diethyl nitrosamine-induced liver tumors in mice. CONCLUSIONS: In rodent HSCs and TICs, we found SCD expression to be regulated by Wnt-β-catenin signaling, and MUFAs produced by SCD provided a forward loop to amplify Wnt signaling via stabilization of Lrp5 and Lrp6 mRNAs, contributing to liver fibrosis and tumor growth. SCD expressed by HSCs promoted liver tumor development in mice. Components of the identified loop linking HSCs and TICs might be therapeutic targets for liver fibrosis and tumors.
引用
- Lai KKY, Kweon SM, Chi F, et al. Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6. Gastroenterology. 2017. PMID: 28143772. doi:10.1053/j.gastro.2017.01.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。